| Oct 9 |
Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology
|
| Oct 7 |
Wall Street Analysts Think Ardelyx (ARDX) Could Surge 65.4%: Read This Before Placing a Bet
|
| Sep 25 |
Ardelyx: Despite Decent Uptake, We Need More Clarity On The Lawsuit
|
| Sep 12 |
Top High Growth Tech Stocks to Watch in September 2024
|
| Sep 5 |
Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference
|
| Aug 30 |
With 62% ownership, Ardelyx, Inc. (NASDAQ:ARDX) boasts of strong institutional backing
|
| Aug 8 |
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
|
| Aug 5 |
Ardelyx Faces Rising Challenges Despite Revenue Growth
|
| Aug 2 |
Ardelyx, Inc. (ARDX) Q2 2024 Earnings Call Transcript
|
| Aug 1 |
Here's What Key Metrics Tell Us About Ardelyx (ARDX) Q2 Earnings
|
